Home >> Pharmaceuticals >> Food & Beverage >>

Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 21 | Code: MRS - 18295

Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Constellation Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Constellation Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Constellation Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Constellation Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Constellation Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Constellation Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Constellation Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Constellation Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Constellation Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Constellation Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Constellation Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Constellation Pharmaceuticals, Inc. Snapshot 4
Constellation Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Constellation Pharmaceuticals, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Constellation Pharmaceuticals, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Constellation Pharmaceuticals, Inc. - Pipeline Products Glance 9
Constellation Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Constellation Pharmaceuticals, Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Constellation Pharmaceuticals, Inc. - Drug Profiles 11
CPI-0610 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
CPI-169 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Small Molecules to Inhibit BET for Cancer 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecules to Inhibit Enhance Zeste Homolog 2 for Cancer 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Constellation Pharmaceuticals, Inc. - Pipeline Analysis 15
Constellation Pharmaceuticals, Inc. - Pipeline Products by Target 15
Constellation Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 16
Constellation Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 17
Constellation Pharmaceuticals, Inc. - Recent Pipeline Updates 18
Constellation Pharmaceuticals, Inc. - Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
Coverage 20
Secondary Research 20
Primary Research 20
Expert Panel Validation 20
Contact Us 20
Disclaimer 21

List of Tables
Constellation Pharmaceuticals, Inc., Key Information 4
Constellation Pharmaceuticals, Inc., Key Facts 4
Constellation Pharmaceuticals, Inc. - Pipeline by Indication, 2015 6
Constellation Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 7
Constellation Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 8
Constellation Pharmaceuticals, Inc. - Phase I, 2015 9
Constellation Pharmaceuticals, Inc. - Preclinical, 2015 10
Constellation Pharmaceuticals, Inc. - Pipeline by Target, 2015 15
Constellation Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 16
Constellation Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 17
Constellation Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 18

List of Figures
Constellation Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 6
Constellation Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 7
Constellation Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 8
Constellation Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 15
Constellation Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 16
Constellation Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 17

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing